4//SEC Filing
Garanzini Michael 4
Accession 0001144204-17-060667
CIK 0001372514other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:15 PM ET
Size
5.1 KB
Accession
0001144204-17-060667
Insider Transaction Report
Form 4
Garanzini Michael
Chief Commercial Officer
Transactions
- Award
Common Stock
2017-11-17$1.07/sh+15,000$16,050→ 15,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.088, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001722844
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:15 PM ET
- Size
- 5.1 KB